Biological markers of Pseudomonas aeruginosa epidemic high-risk clones

Xavier Mulet1, Gabriel Cabot, Alain A Ocampo-Sosa

  • 1Servicio de Microbiología y Unidad de Investigación, Hospital Universitario Son Espases, Palma de Mallorca, Spain.

Insights

High-risk Pseudomonas aeruginosa clones, responsible for global nosocomial infections, exhibit enhanced biofilm formation and mutation rates but reduced motility and virulence factors. These traits aid in adaptation to chronic infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa, particularly high-risk clones like ST-111, ST-175, and ST-235, cause widespread nosocomial infections.
  • Understanding the biological underpinnings of these successful clones is crucial for developing effective control strategies.

Purpose of the Study:

  • To investigate the biological parameters differentiating high-risk MDR/XDR Pseudomonas aeruginosa clones from susceptible strains.
  • To identify potential markers associated with the success and epidemic potential of specific P. aeruginosa genotypes.

Main Methods:

  • Analysis of 20 isolates each from XDR, MDR, ModR, and MultiS resistance groups from a multicenter study in Spain.
  • Genotyping using multilocus sequence typing (MLST) to identify high-risk clones.
  • Evaluation of motility (twitching, swimming, swarming), biofilm formation, pyoverdine/pyocyanin production, mutant frequencies, and in vitro competition index (CI) using flow cytometry.

Main Results:

  • High-risk clones predominated in XDR (100%), MDR (40%), and ModR (5%) bloodstream isolates.
  • MDR/XDR high-risk clones demonstrated significantly increased biofilm formation and spontaneous mutant frequencies.
  • Conversely, these clones exhibited significantly reduced motility, pyoverdine/pyocyanin production, and overall fitness compared to susceptible strains.

Conclusions:

  • Specific biological markers, including enhanced biofilm formation and increased mutation rates, characterize successful high-risk Pseudomonas aeruginosa clones.
  • These traits, resembling adaptations for chronic infections, offer potential targets for novel therapeutic and infection control interventions.
  • Identifying these biological markers can aid in predicting and managing outbreaks of resistant P. aeruginosa infections.